Skip to search formSkip to main contentSkip to account menu

Toxoplasmosis, Cerebral

Known as: Toxoplasmosis, Cerebral [Disease/Finding], Toxoplasmoses, Cerebral, cns toxoplasmosis 
Infections of the BRAIN caused by the protozoan TOXOPLASMA gondii that primarily arise in individuals with IMMUNOLOGIC DEFICIENCY SYNDROMES (see also… 
National Institutes of Health

Related topics

Related topics

12 relations
AIDS-Related Opportunistic InfectionsAtovaquoneIn BloodInflammation

Broader (3)

NeurotoxoplasmosisToxoplasmosisToxoplasmosis, Central Nervous System

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
HIV‐associated central nervous system diseases in the recent combination antiretroviral therapy era
Background and purpose:  Data describing the incidence and survival of HIV‐related central nervous system diseases (CNS‐D) in… 
Review
2009
Review
2009
Current status of toxoplasmosis vaccine development
Toxoplasmosis, caused by an intracellular protozoan parasite, Toxoplasma gondii, is widespread throughout the world. The disease… 
Highly Cited
2005
Highly Cited
2005
The prevalence and risk of immune restoration disease in HIV‐infected patients treated with highly active antiretroviral therapy
It is becoming increasingly clear that, during successful highly active antiretroviral therapy (HAART), a proportion of treated… 
Highly Cited
2003
Highly Cited
2003
Differentiation of toxoplasmosis and lymphoma in AIDS patients by using apparent diffusion coefficients.
BACKGROUND AND PURPOSE Distinguishing between toxoplasmosis and lymphoma brain lesions in AIDS patients is difficult but… 
Highly Cited
2002
Highly Cited
2002
Chemokines are differentially expressed by astrocytes, microglia and inflammatory leukocytes in Toxoplasma encephalitis and critically regulated by interferon-γ
Abstract. The intracerebral formation of inflammatory infiltrates is a complex process, which may be regulated by chemokines… 
Highly Cited
2001
Highly Cited
2001
Atovaquone Nanosuspensions Show Excellent Therapeutic Effect in a New Murine Model of Reactivated Toxoplasmosis
ABSTRACT Immunocompromised patients are at risk of developing toxoplasma encephalitis (TE). Standard therapy regimens (including… 
Highly Cited
2000
Highly Cited
2000
Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART)
OBJECTIVE To determine the change of incidence and prevalence of neurological disorders caused by the human immunodeficiency… 
Review
1995
Review
1995
Central nervous system tuberculosis in HIV-infected patients: clinical and radiographic findings.
PURPOSE To characterize the radiographic findings on neuroimaging of 25 human immunodeficiency virus (HIV)-seropositive patients… 
Highly Cited
1994
Highly Cited
1994
Differential Expression of ICAM-1, VCAM-1 and Their Ligands LFA-1, Mac-1, CD43, VLA-4, and MHC Class II Antigens in Murine Toxoplasma Encephalitis: A Light Microscopic and Ultrastructural…
Light microscopic and ultrastructural immunohistochemistry of cell adhesion molecules (CAMs) and major histocompatibility class… 
Highly Cited
1993
Highly Cited
1993
Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-alpha and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage…
C57BL/6 mice infected with the ME-49 strain of Toxoplasma gondii develop a progressive encephalitis culminating in 100% mortality… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)